Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Can you tell me more about the the MedImmune H1N1 nasal spray vaccine recall?

0
Posted

Can you tell me more about the the MedImmune H1N1 nasal spray vaccine recall?

0

• On December 23rd certain lots of the MedImmune nasal spray vaccine were recalled but not due to purity, potency or safety issues. • The recall was due to postproduction monitoring efforts that found select batches (or lots) of vaccine that did not meet manufacturing specifications. • Florida received 297,650 doses of the recalled vaccine. • Those that have received the designated lots of vaccine, do not need to be revaccinated – it is an effective vaccine. Therefore, individuals that received the identified lots of vaccine will not be notified. • If a child has received the initial dose of H1N1 vaccine, they should receive the 2nd dose as directed. • Providers will be contacted by the manufacturer (MedImmune) with instructions for returning any unused vaccine from the following lots to the manufacturer: 500754P 500751P 500756P 500757P 500758P 500759P 500760P 500761P 500762P 500763P 500764P 500765P 500776P • Providers must reorder vaccine through the established procedures [utilizing

0
10

• On December 23rd certain lots of the MedImmune nasal spray vaccine were recalled but not due to purity, potency or safety issues. • The recall was due to postproduction monitoring efforts that found select batches (or lots) of vaccine that did not meet manufacturing specifications. • Florida received 297,650 doses of the recalled vaccine. • Those that have received the designated lots of vaccine, do not need to be revaccinated – it is an effective vaccine. Therefore, individuals that received the identified lots of vaccine will not be notified. • If a child has received the initial dose of H1N1 vaccine, they should receive the 2nd dose as directed. • Providers will be contacted by the manufacturer (MedImmune) with instructions for returning any unused vaccine from the following lots to the manufacturer: 500754P 500751P 500756P 500757P 500758P 500759P 500760P 500761P 500762P 500763P 500764P 500765P 500776P • Providers must reorder vaccine through the established procedures [utilizing

Related Questions

What is your question?

*Sadly, we had to bring back ads too. Hopefully more targeted.

Experts123